←Back to Expert Scholars
Translational Medicine / 转化医学Historical Oncology Leadership
Emil Frei III
MD
🏢Dana-Farber Cancer Institute🌐USA
Former Physician-in-Chief (Historical)
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Emil Frei III was a foundational figure in combination chemotherapy and contributed to the first curative regimens for childhood acute lymphoblastic leukemia. He went on to lead the Dana-Farber Cancer Institute and shaped modern clinical cancer research for decades.
Share:
🧪Research Fields 研究领域
combination chemotherapy
childhood leukemia
VAMP regimen
historical oncology
clinical cancer research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Emil Frei III 的研究动态
Follow Emil Frei III's research updates
留下邮箱，当我们发布与 Emil Frei III（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment